The new spinal fixation systems include the Cervical Stand-alone IBD, Vu CPOD Non-Strut IBD and Steerable IBD. The IBDs are small hollow implants that are inserted into intervertebral space to restore physiological disc height and allow fusion between vertebral bodies.
The devices are designed to maintain the natural disc space height and provide positive mechanical stabilization of the vertebrae, which relives pressure on the nerves. The devices’ graft window allows natural bone growth to occur through the IBD.
The devices are currently in limited commercial release and are targeted for full commercial release later this year.
Read the Integra LifeSciences release on the spine devices.
Read other coverage on Integra LifeSciences:
– Integra LifeSciences Launches Integra Allograft Cancellous Sponge
– Integra LifeSciences to Feature Total Wrist Fusion System for Arthritis Treatment
– Integra LifeSciences Reports $194.1M 4Q Revenue, 6% Increase
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
